Investing Profile
Richard Heyman
InvestorVC
Venture Partner at ARCH Venture Partners
archventure.com/team/richard-...Encinitas, California
Your Intro Paths to Richard Heyman
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Richard is a member of
University of Minnesota Network
54 CONNECTIONS
ARCH Venture Partners Network
25 CONNECTIONS
Find Richard Heyman on
cbCurrent Investing Position
ARCH Venture Partners Venture Partner
Investment Range
$50K - $150.0M
Sweet Spot
$25.0M
Investments On Record
1
Current Fund Size
$635.8M
Richard Heyman is on these Sector & Stage Rankings
Richard Heyman's Investments On Record (1)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Pelage Pharmaceuticals | Series BOct 2025$120M | $150M |
Richard Heyman's Experience
Chairperson of the Board RayzeBio2022 - Present
Board of Director and Scientific Advisory Board Member Curebound2021 - Present
BOD Member/Chairman Enliven Therapeutics2020 - Present
Chairman of the Board PMV Pharmaceuticals, Inc.2020 - Present
Venture Partner ARCH Venture Partners2020 - Present
Board of Managers Life Science Cares San Diego2020 - Present
Chairman/BOD member Vividion Therapeutics, Inc.2018 - Present
Vice Chairman of The Board of Trustees Salk Institute for Biological Studies2015 - Present
Chairman of the BOD Aragon Pharmaceuticals2014 - Present
Member Board of Trustees Salk Institute for Biological StudiesPresent
BOD Member Gritstone bioPresent
BOD Member Exelixis, Inc.Present
BOD member/Former Chairman Vividion Therapeutics, Inc.Present
Board of Managers Utah Life Science Industry AssociationPresent
Board Member and Scientific Advisory Board Member CureboundPresent
Chairman of the Board RayzeBioPresent
Board Member Pelage PharmaceuticalsPresent
President and CEO Exelixis, Inc.Present
Science Partner Exelixis, Inc.Present
Chairman of the BOD and Co-Founder Exelixis, Inc.Present
Executive Chairman Metacrine Inc.2015 - 2022
Chairperson of the Board Amunix Pharmaceuticals2019 - 2021
BOD Member Yumanity Therapeutics2016 - 2021
BOD Member Gritstone Oncology2015 - 2021
President and CEO Seragon Pharmaceuticals2013 - 2015
President and CEO Aragon Pharmaceuticals2009 - 2013
Chief Scientific Officer Kalypsys, Inc.2006 - 2008
Sr. Vice President Exelixis, Inc.2004 - 2006
CSO X-Ceptor Therapeutics1999 - 2006
VP Research Ligand Pharmaceuticals1990 - 1999
Postdoctoral Fellow Salk Institute1986 - 1990
Richard Heyman's Education
University of Minnesota PhD Pharmacology
Investors who invest with Richard Heyman
Sign in with Google →Scouts & Angels Affiliated With Richard Heyman
Sign in with Google →